15.21

3.80% -0.60

Assembly Biosciences Inc (ASMB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$15.81

Aprire:

$15.7

Volume 24 ore:

30,654

Relative Volume:

0.87

Capitalizzazione di mercato:

$96.68M

Reddito:

Utile/perdita netta:

$-61.23M

Rapporto P/E:

-9.3313

EPS:

-1.63

Flusso di cassa netto:

$22.49M

1 W Prestazione:

-1.11%

1M Prestazione:

+1.26%

6M Prestazione:

-0.59%

1 anno Prestazione:

+64.61%

Intervallo 1D:

$15.00

$16.26

Intervallo di 1 settimana:

$13.20

$16.75

Portata 52W:

$9.1032

$19.93

Assembly Biosciences Inc Stock (ASMB) Company Profile

Nome

Assembly Biosciences Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

(833) 409-4583

Indirizzo

TWO TOWER PLACE, SOUTH SAN FRANCISCO

Dipendente

Cinguettio

Prossima data di guadagno

2024-12-06

Ultimi documenti SEC

ASMB's Discussions on Twitter

Confronta ASMB con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ASMB Assembly Biosciences Inc	15.21	96.68M	0	-61.23M	22.49M	-13.52
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-09-20	Aggiornamento	Jefferies	Hold → Buy
2021-09-13	Iniziato	H.C. Wainwright	Neutral
2021-09-02	Downgrade	William Blair	Outperform → Mkt Perform
2021-03-23	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-11-06	Downgrade	Jefferies	Buy → Hold
2020-10-19	Iniziato	Truist	Buy
2019-10-16	Iniziato	Mizuho	Buy
2018-11-19	Iniziato	Leerink Partners	Outperform
2018-10-08	Aggiornamento	B. Riley FBR	Neutral → Buy
2018-08-08	Iniziato	Robert W. Baird	Outperform
2018-04-13	Downgrade	Chardan Capital Markets	Buy → Neutral
2018-01-05	Iniziato	B. Riley FBR, Inc.	Neutral
2017-11-08	Iniziato	Jefferies	Buy
2017-05-30	Iniziato	Chardan Capital Markets	Buy

Mostra tutto

Assembly Biosciences Inc Borsa (ASMB) Ultime notizie

Dec 21, 2024

Assembly Biosciences (NASDAQ:ASMB) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Dec 21, 2024

Dec 20, 2024

Gilead raises Assembly Bio stake to ~30% - MSN

Dec 20, 2024

Gilead invests in Assembly Bio to advance clinical programs - The Pharma Letter

Dec 20, 2024

Gilead boosts stake in Assembly Bio with $30.1 million investment By Investing.com - Investing.com Canada

Dec 20, 2024

Dec 19, 2024

Assembly Biosciences strikes amended deal with Gilead - Investing.com

Dec 19, 2024

Assembly Biosciences strikes amended deal with Gilead By Investing.com - Investing.com UK

Dec 19, 2024

Assembly Bio stock rises as Gilead ups stake (ASMB:NASDAQ) - Seeking Alpha

Dec 19, 2024

Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding - MarketWatch

Dec 19, 2024

Assembly Biosciences Gets $30.1M Equity Investment, Funding From Gilead - MarketWatch

Dec 19, 2024

Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs - The Manila Times

Dec 19, 2024

Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from - The Bakersfield Californian

Dec 19, 2024

Assembly Bio Secures $30.1M Gilead Investment, Advancing Ambitious Antiviral Pipeline - StockTitan

Dec 19, 2024

(ASMB) Trading Advice - Stock Traders Daily

Dec 19, 2024

Dec 14, 2024

Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Significant Growth in Short Interest - MarketBeat

Dec 14, 2024

Dec 09, 2024

Reviewing BeiGene (NASDAQ:BGNE) and I-Mab (NASDAQ:IMAB) - Defense World

Dec 09, 2024

Dec 08, 2024

How the (ASMB) price action is used to our Advantage - Stock Traders Daily

Dec 08, 2024

Nov 30, 2024

Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Large Increase in Short Interest - MarketBeat

Nov 30, 2024

Nov 26, 2024

Assembly Biosciences investor Alexander Schornstein buys $372,994 in shares By Investing.com - Investing.com

Nov 26, 2024

Novavax and Assembly lead infectious disease gainers in 2024 - BioWorld Online

Nov 26, 2024

Nov 23, 2024

Comparing Cardiol Therapeutics (NASDAQ:CRDL) & Gilead Sciences (NASDAQ:GILD) - Defense World

Nov 23, 2024

Nov 22, 2024

Genome Editing Market Size Projected to Reach USD 32.72 - GlobeNewswire

Nov 22, 2024

Nov 21, 2024

Assembly Biosciences Reports Q3 2024 Financials and Strategic Advances - TipRanks

Nov 21, 2024

Nov 17, 2024

(ASMB) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Nov 17, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Adjusts Stake in Assembly Biosciences Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

HC Wainwright Has Optimistic Outlook of ASMB FY2024 Earnings - MarketBeat

Nov 14, 2024

Nov 13, 2024

Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Down 51.2% in October - MarketBeat

Nov 13, 2024

Analysts Just Slashed Their Assembly Biosciences, Inc. (NASDAQ:ASMB) EPS Numbers - Simply Wall St

Nov 13, 2024

Bearish: Analysts Just Cut Their Assembly Biosciences, Inc. (NASDAQ:ASMB) Revenue and EPS estimates - Yahoo Finance

Nov 13, 2024

Nov 12, 2024

Analyzing Taysha Gene Therapies (NASDAQ:TSHA) & Gilead Sciences (NASDAQ:GILD) - Defense World

Nov 12, 2024

Nov 08, 2024

Assembly Biosciences: Q3 Earnings Snapshot - CTPost

Nov 08, 2024

Assembly Biosciences Reports Third Quarter 2024 Financial Results and Recent Updates - The Manila Times

Nov 08, 2024

Nov 07, 2024

Assembly Biosciences initiates at-the-market equity program - Investing.com India

Nov 07, 2024